​

ARS Pharmaceuticals Ownership | Who Owns ARS Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

ARS Pharmaceuticals Ownership Summary

ARS Pharmaceuticals is owned by 66.02% institutional investors, 23.16% insiders, and 10.83% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.05% of its assets in ARS Pharmaceuticals shares.

SPRY Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockARS Pharmaceuticals66.02%23.16%10.83%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202416235.00%64,056,6692.41%661.58%10351.47%268.33%
Jun 30, 20241201.69%62,551,0554.44%641.68%683.03%24-4.00%
Mar 31, 202411812.38%59,892,346-8.46%621.35%6637.50%25-16.67%
Dec 31, 2023105-0.94%65,425,953-1.66%671.40%48-20.00%3030.43%
Sep 30, 20231067.07%66,527,96220.80%692.07%60-6.25%2321.05%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.99M2.05%-
SPDR® S&P Biotech ETF1.60M1.65%-18.68K
iShares Russell 2000 ETF1.34M1.38%-5.15K
Franklin Biotechnology Discv A(acc)USD1.23M1.26%-423.10K
MEDICAL BioHealth EUR Acc1.12M1.15%85.00K
Fidelity Select Biotechnology1.08M1.11%-
AB Small Cap Growth A1.02M1.05%1.02M
Vanguard Institutional Extnd Mkt Idx Tr777.20K0.80%-43.01K
Franklin Biotechnology Discovery A718.99K0.74%-238.00K
AB Discovery Growth A691.59K0.71%691.59K

Recent Insider Transactions

DateNameRoleActivityValue
Jan 06, 2025Shawver Laura-Sell$555.07K
Dec 17, 2024Tanimoto Sarina CHIEF MEDICAL OFFICERSell$583.52K
Dec 17, 2024Tanimoto Sarina CHIEF MEDICAL OFFICERSell$583.58K
Dec 17, 2024Lowenthal Richard E PRESIDENT AND CEOSell$583.52K
Dec 17, 2024Lowenthal Richard E PRESIDENT AND CEOSell$583.58K

Insider Transactions Trends

DateBuySell
2024 Q4-58
2024 Q3-51
2024 Q2-32
2024 Q1344
2023 Q379

SPRY Ownership FAQ

Who Owns ARS Pharmaceuticals?

ARS Pharmaceuticals shareholders are primarily institutional investors at 66.02%, followed by 23.16% insiders and 10.82% retail investors. The average institutional ownership in ARS Pharmaceuticals's industry, Biotech Stocks , is 109.70%, which ARS Pharmaceuticals falls below.

Does Blackrock own ARS Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of ARS Pharmaceuticals.

Who is the top mutual fund holder of ARS Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of ARS Pharmaceuticals shares, with 2.05% of its total shares outstanding invested in 1.99M ARS Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools